160 related articles for article (PubMed ID: 9769114)
1. T cell-tumor cell: a fatal interaction?
Chappell DB; Restifo NP
Cancer Immunol Immunother; 1998 Oct; 47(2):65-71. PubMed ID: 9769114
[TBL] [Abstract][Full Text] [Related]
2. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
3. Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack.
O'Connell J; Bennett MW; O'Sullivan GC; Collins JK; Shanahan F
Dis Esophagus; 1999; 12(2):83-9. PubMed ID: 10466039
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction.
Ju ST; Matsui K; Ozdemirli M
Int Rev Immunol; 1999; 18(5-6):485-513. PubMed ID: 10672498
[TBL] [Abstract][Full Text] [Related]
5. Cells behaving badly: a theoretical model for the Fas/FasL system in tumour immunology.
Webb SD; Sherratt JA; Fish RG
Math Biosci; 2002; 179(2):113-29. PubMed ID: 12208611
[TBL] [Abstract][Full Text] [Related]
6. Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict.
O'Connell J; Bennett MW; Nally K; Houston A; O'Sullivan GC; Shanahan F
Ann N Y Acad Sci; 2000 Jun; 910():178-92; discussion 193-5. PubMed ID: 10911913
[TBL] [Abstract][Full Text] [Related]
7. Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase.
Zhang J; Gao JX; Salojin K; Shao Q; Grattan M; Meagher C; Laird DW; Delovitch TL
J Exp Med; 2000 Mar; 191(6):1017-30. PubMed ID: 10727463
[TBL] [Abstract][Full Text] [Related]
8. Caspase activation is required for T cell proliferation.
Kennedy NJ; Kataoka T; Tschopp J; Budd RC
J Exp Med; 1999 Dec; 190(12):1891-6. PubMed ID: 10601363
[TBL] [Abstract][Full Text] [Related]
9. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
O'Connell J; O'Sullivan GC; Collins JK; Shanahan F
J Exp Med; 1996 Sep; 184(3):1075-82. PubMed ID: 9064324
[TBL] [Abstract][Full Text] [Related]
10. Actinobacillus actinomycetemcomitans induces apoptosis of T lymphocytes by the Fas and Fas ligand pathway.
Nalbant A; Zadeh HH
Oral Microbiol Immunol; 2002 Oct; 17(5):277-84. PubMed ID: 12354208
[TBL] [Abstract][Full Text] [Related]
11. Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege.
O'Connell J; Bennett MW; O'Sullivan GC; O'Callaghan J; Collins JK; Shanahan F
Clin Diagn Lab Immunol; 1999 Jul; 6(4):457-63. PubMed ID: 10391843
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance.
Villunger A; Egle A; Marschitz I; Kos M; Böck G; Ludwig H; Geley S; Kofler R; Greil R
Blood; 1997 Jul; 90(1):12-20. PubMed ID: 9207432
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes.
Cippitelli M; Fionda C; Di Bona D; Di Rosa F; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2002 Feb; 168(3):1154-66. PubMed ID: 11801650
[TBL] [Abstract][Full Text] [Related]
14. Cell death induced by the Fas/Fas ligand pathway and its role in pathology.
Waring P; Müllbacher A
Immunol Cell Biol; 1999 Aug; 77(4):312-7. PubMed ID: 10457197
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively.
Tóth R; Szegezdi E; Molnár G; Lord JM; Fésüs L; Szondy Z
Eur J Immunol; 1999 Feb; 29(2):383-93. PubMed ID: 10064053
[TBL] [Abstract][Full Text] [Related]
16. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.
Kaser A; Nagata S; Tilg H
Cytokine; 1999 Oct; 11(10):736-43. PubMed ID: 10525311
[TBL] [Abstract][Full Text] [Related]
17. Zeta-associated protein of 70 kDa (ZAP-70), but not Syk, tyrosine kinase can mediate apoptosis of T cells through the Fas/Fas ligand, caspase-8 and caspase-3 pathways.
Zhong L; Wu CH; Lee WH; Liu CP
J Immunol; 2004 Feb; 172(3):1472-82. PubMed ID: 14734724
[TBL] [Abstract][Full Text] [Related]
18. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway.
Tateyama M; Oyaizu N; McCloskey TW; Than S; Pahwa S
Blood; 2000 Jul; 96(1):195-202. PubMed ID: 10891451
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death.
Ayroldi E; Zollo O; Cannarile L; D' Adamio F; Grohmann U; Delfino DV; Riccardi C
Blood; 1998 Dec; 92(11):4212-9. PubMed ID: 9834226
[TBL] [Abstract][Full Text] [Related]
20. Expression of Fas ligand is not a main mechanism used by tumors to counteract antitumor immunity.
Chen CM; Song W; Kao JY; Zheng QD; Chen JJ
Front Biosci; 2004 Jan; 9():448-56. PubMed ID: 14766381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
